300791 logo

Sirio Pharma Co., Ltd. Stock Price

SZSE:300791 Community·CN¥5.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300791 Share Price Performance

CN¥16.36
-6.81 (-29.39%)
CN¥16.36
-6.81 (-29.39%)
Price CN¥16.36

300791 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with moderate growth potential.

3 Risks
1 Reward

Sirio Pharma Co., Ltd. Key Details

CN¥4.3b

Revenue

CN¥3.1b

Cost of Revenue

CN¥1.2b

Gross Profit

CN¥1.1b

Other Expenses

CN¥117.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 29, 2026
0.38
28.50%
2.73%
50.5%
View Full Analysis

About 300791

Founded
1993
Employees
2776
CEO
Peiqing Li
WebsiteView website
www.siriopharma.com

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

Recent 300791 News & Updates

Recent updates

No updates